6 Comments
User's avatar
NatteringNaybob's avatar

Cyprinus Carpio - Part 3 of another magnum opus.

From Part 1: "The active-control vaccine (Comirnaty) used in the Japanese phase III study (Study ARCT-154-J01) is a replicon-non-containing RNA vaccine."

A VRP by another name. Not unrelated...

From Part 3: "Although the manufacturer may choose to use these patented IIPs there is a viral protein group that also acts as an IIP that has to be used. Without it, a replicon vaccine is no longer a replicon vaccine."

It's the mimicry that gets one to hold their beer, and it works something like this... https://youtu.be/HrENha7E1xc?

Can't wait for Part 4. FYI - Your up on Ah Kahn Syed's latest.

Expand full comment
DoorlessCarp🐭's avatar

Thanks NNB. The patents are interesting as they reveal more than the paid off regulators do. Although you can't usually patent a natural protein, there are exceptions.

They don't say which ones they actually use, but they give a long list and most of them are linked to cancer progression.

Expand full comment
Amat's avatar

All of these extremely complex immune pathways doing different things at different times for different reasons causing different effects for different people should never have been interfered with.It was and is madness, the mRNA platform should never have left the theoretical realm. The immune system is so complex we had no business experimenting with it on humans. Our immune system is the best defence barrier we have against many diseases, to interfere with that complex structure is unconscionable, that is what has been done on a worldwide scale with no true understanding of the possible outcomes.

Expand full comment
DoorlessCarp🐭's avatar

Either it's done maliciously: Go to jail,

or its reckless endangerment: Go to jail.

Expand full comment
gusman's avatar

sv40

Expand full comment
DoorlessCarp🐭's avatar

Indeed. I'm not aware of either SV40 promoter or whole virus contamination of saRNA vaccines as it's manufactured using different processes, but it's one to look out for.

Expand full comment